FORWARD PHARMA A/S
SPONSORD ADS NEW · CUSIP 34986J204
8
institutional holders
909.1k
shares reported held*
$2.7mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.95.
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| BVF INC/IL 0.06% of their portfolio | 513.8k $1.5m | — |
| MORGAN STANLEY 0.00% of their portfolio | 163.3k $483.0k | — |
| MASON CAPITAL MANAGEMENT LLC 0.17% of their portfolio | 150.2k $445.0k | — |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 61.5k $181.0k | — |
| Perigon Wealth Management, LLC 0.00% of their portfolio | 18.1k $54.0k | — |
| UBS Group AG 0.00% of their portfolio | 2.2k $6.0k | — |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1 $0 | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |